Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauro M Takeuchi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Molecular Sciences|June 24, 2022
<i>Col4a3</i> Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 BackgroundsCamila I Irion, Monique Williams, Jose Condor Capcha, et al.
Cardiovascular Research|June 15, 2022
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fractionRaul A Dulce, Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarctionRosemeire M Kanashiro-Takeuchi, Konstantinos Tziomalos, Lauro M Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Journal of the American College of Cardiology|June 1, 2019
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial PathwayKeyvan Yousefi, Camila I Irion, Lauro M Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fractionAngela C Rieger, Luiza L Bagno, Alessandro Salerno, et al.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Molecular Sciences|June 24, 2022
<i>Col4a3</i> Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 BackgroundsCamila I Irion, Monique Williams, Jose Condor Capcha, et al.
Cardiovascular Research|June 15, 2022
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fractionRaul A Dulce, Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarctionRosemeire M Kanashiro-Takeuchi, Konstantinos Tziomalos, Lauro M Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Journal of the American College of Cardiology|June 1, 2019
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial PathwayKeyvan Yousefi, Camila I Irion, Lauro M Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fractionAngela C Rieger, Luiza L Bagno, Alessandro Salerno, et al.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Pageof 2